Works matching IS 2732-7787 AND VI 3 AND IP 3 AND DT 2023


Results: 20
    1
    2
    3
    4
    5
    6

    Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma.

    Published in:
    Cancer Diagnosis & Prognosis, 2023, v. 3, n. 3, p. 370, doi. 10.21873/cdp.10226
    By:
    • TERUO INAMOTO;
    • RYO SATO;
    • YUTO MATSUSHITA;
    • TAIZO UCHIMOTO;
    • KO NAKAMURA;
    • KAZUMASA KOMURA;
    • KAZUKI NISHIMURA;
    • YUSUKE YANO;
    • KYOSUKE NISHIO;
    • SHOKO KINOSHITA;
    • TATSUO FUKUSHIMA;
    • TOMOHISA MATSUNAGA;
    • KEITA NAKAMORI;
    • TAKESHI TSUTSUMI;
    • TAKUYA TSUJINO;
    • HIROFUMI UEHARA;
    • KIYOSHI TAKAHARA;
    • HIDEAKI MIYAKE;
    • HARUHITO AZUMA
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Calpain-mediated Mechanoptosis in Breast Adenocarcinoma.

    Published in:
    Cancer Diagnosis & Prognosis, 2023, v. 3, n. 3, p. 297, doi. 10.21873/cdp.10215
    By:
    • METAXAS, GEORGIOS I.;
    • SPYROPOULOU, DESPOINA;
    • MASTRONIKOLI, SOFIANIKI;
    • TSIAMBAS, EVANGELOS;
    • FALIDAS, EVANGELOS;
    • MARINOPOULOS, SPYRIDON;
    • MANAIOS, LOUKAS;
    • DAVRIS, DIMITRIOS;
    • FOTIADES, PANAGIOTIS;
    • PESCHOS, DIMITRIOS;
    • DIMITRAKAKIS, CONSTANTINE
    Publication type:
    Article
    18
    19
    20